References
JJV McMurray, MC Petrie, DR Murdoch and AP Davie, Clinical epidemiology of heart failure: public and private health burden. Eur Heart J 19 (1998) P9-P16
The National Collaborating Centre for Chronic Conditions. Chronic heart failure. National clinical guideline for diagnosis and management in primary and secondary care. 2003; NICE Guideline No. 5. Royal Col lege of Physicians of London.
J Remes, H Miettinen, A Reunanen and K Pyorala, Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 12 (1991) 315-321
CM Francis, L Caruana and P Kearney, Open access echocardiography in management of heart failure in community. BMJ 310 (1995) 634-636
H Rimington, G Adam and J Chambers, Open-access echocardiography. Lancet 348 (1996) 555-556
Baur LHB, Lenderink T, Lodewijks C, Veenstra L, Winkens R. Easy access echocardiography for the general practicioner: results from the Parkstad area in The Netherlands. Int J Cardiovasc Imaging 2005; DOI: 10.1007/s10554-005-6915-z
MC Petrie, K Hogg, L Caruana and JJV McMurray, Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction?. Heart 90 (2004) 511-517
A Salustri and P Trambaiolo, The “ultrasonic stethoscope”: is it of clinical value?. Heart 89 (2003) 704-706
GIW Galasko, A Lahiri and R Senior, Portable echocardiography: an innovative tool in screening for cardiac abnormalities in the community. Eur J Echocardiogr 4 (2003) 119-127
MR Cowie, AD Struthers and DA Wood, Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 (1997) 1347-1351
JA Lemos de, DK McGuire and MH Drazner, B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-22
TA McDonagh, SD Robb and DR Murdoch, Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
Galasko GIW, Lahiri A, Barnes SC, Collinson P, Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J 2005, in press
PO Collinson, SC Barnes, DC Gaze, G Galasko, A Lahiri and R Senior, Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 6 (2004) 365-368
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Galasko, G.I.W., Henein, M. Direct Access Echocardiography. Int J Cardiovasc Imaging 22, 29–31 (2006). https://doi.org/10.1007/s10554-005-0721-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-005-0721-5